iRhythm Technologies Inc (LTS:0A7L)
$ 86.405 0.635 (0.74%) Market Cap: 2.72 Bil Enterprise Value: 2.93 Bil PE Ratio: 0 PB Ratio: 36.41 GF Score: 71/100

iRhythm Technologies Inc at JPMorgan Healthcare Conference Transcript

Jan 13, 2020 / 11:00PM GMT
K. Gong
JP Morgan Chase & Co, Research Division - Analyst

Okay. I want to thank everyone for being here. My name is Allen Gong. I'm on the medical supplies and devices team with JPMorgan. It's my pleasure to introduce Kevin King, the President and CEO of iRhythm, for prepared remarks. Afterwards, we'll be hosting a breakout in the Yorkshire room. Kevin?

Kevin M. King
iRhythm Technologies, Inc. - President, CEO & Director

Thank you. Hi, everyone. Are you able to hear me in the back? Great. Thank you for coming. It's great to be back here. I think this is our fifth year presenting and third year as a public company, so we're really excited. By now, you've seen safe harbor statements. It's 3:00 in the afternoon. I refer you to irhythmtech.com if you have questions about risk factors, forward-looking statements, et cetera.

My presentation today is going to be divided up into 3 sections. I'm going to speak with you about how we view our markets or the attractiveness of our markets. I'll talk to you about what we believe are the key

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot